SupplySide Global

At SupplySide Global 2025, Dr. Sanjay Tamoli and Harris Sheikh, Co-Founders and Partners, Logical Square discuss CaFi and its digestive health benefits.

At SupplySide Global 2025, Antonio Vendrell, marketing and communication director at Bioiberica, discusses research on Collavant n2 for joint health.

At SupplySide Global 2025, Frank Behnam, CEO of Aquanova AG, and Danny Hofeditz, Director Quality & Product Innovation, Prokurist, Aquanova AG, discuss some of the upcoming research from the company.

At SupplySide Global 2025, Florencia Moreno Torres, global marketing manager for Rousselot, Inc, discusses Nextida GC and its effect on boosting GLP-1 secretion.

At this year’s SupplySide Global 2025 conference, California Natural Color will highlight their natural color solutions to attendees.

Gencor recently announced that it will be launching a nutraceutical arm under the name of Saanroo. We interviewed John Quilter, the CEO of Saanroo, at SupplySide Global 2025 to learn more about this rebrand and why it was important.

At SupplySide Global 2025, Jordi Riera, chief business development manager at Kaneka Probiotics discusses innovations in women's health and probiotics.

This educational session provided an expert panelist discussion on overcoming supply chain challenges.

Univar Solutions will showcase various dosage formats at Supply Side Global 2025, including orally disintegrating tablets, effervescent tablets, and capsules, tailored to nutraceutical applications. The company is also addressing the growing demand for GLP-1 receptor agonist drugs by offering solutions for dehydration, and satiety. Univar's approach to healthy aging focuses on mobility, cognition, and digestive health, emphasizing lifelong protocols and science-backed ingredients.

At SupplySide Global 2025, Amano Enzyme USA will showcase their enzyme portfolio offerings to event attendees.

Saanroo will operate as a separate nutraceutical division, while Gencor Pacific will continue to operate a pharmaceutical arm.

At SupplySide Global 2025, NuAxon Bioscience Inc. disclosed that the company would be highlighting new research on their BacoZen ingredient.